Health Insurers Target Real-Time Prior Authorization by 2027

U.S. health insurers aim to achieve real-time prior authorization by 2027, resulting in an 11% reduction in request volumes and the elimination of 6.5 million transactions over ten months. This initiative enhances electronic systems to provide immediate determinations at the point of care, targeting around 80% on-the-spot processing of electronic requests. Such a transformation necessitates technical upgrades and closer alignment with healthcare providers for seamless operations.

The reduction in prior authorization follows a 2025 pledge by over 40 insurers to streamline approval processes, affecting Medicare Advantage and some commercial plans. As reported by Best Wire, these changes have notably decreased authorization requests across various medical services. This initiative also aims to simplify processes for policyholders, reduce administrative burdens on providers, and provide clearer authorization decision explanations.

For Medicare Advantage, prior authorization usage decreased by over 15%, highlighting disparities in utilization management compared to traditional Medicare, which does not utilize prior authorizations. Federal data from 2024 shows diversity in insurers’ use of authorizations and denial rates. Plans with fewer requests might have higher denial rates, while those requiring more authorizations reflect a different management approach.

Insurers have eased prior authorization requirements for services with consistent clinical guidelines, focusing on stable categories of care. They have agreed to honor existing authorizations for 90 days during plan transitions to ensure continuity, supported by established data-sharing protocols between insurers. Despite these advancements, authorization remains contentious, with surveys indicating delays, denials, or altered treatments affecting nearly half of insured adults.

Employer and purchaser groups recognize these changes as progress but highlight the ongoing need to reduce administrative hurdles impacting employees and dependents. While these reforms are voluntary, insurers face pressure to improve transparency in reporting authorization and denial metrics, especially concerning employer-sponsored plans and prescription drug requests.

Regulatory bodies are scrutinizing these changes, with potential interventions looming if progress stalls. Currently, these adjustments impact insurers servicing over 250 million Americans. While the significant reduction in prior authorization volumes is evident, insurers assert that these processes are crucial for cost management and appropriate healthcare use. Further developments are expected as insurers refine electronic systems and adjust protocols in partnership with healthcare providers.